Kahn Brothers Group Inc – BMY history
- Issuer:
- Bristol-Myers Squibb
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 170,381
- Current value:
- $10.33M
- Peak shares:
- 833,916 (Q4 2023)
- Overall change:
- -80%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 170,381 | $10.33M | $60.65 | -31,815 | -16% |
| Q4 2025 | 202,196 | $10.91M | $53.94 | -70,138 | -26% |
| Q3 2025 | 272,334 | $12.28B | $45100.00 | 0 | 0% |
| Q3 2025 | 272,334 | $12.28M | $45.10 | -278,349 | -51% |
| Q2 2025 | 550,683 | $25.49M | $46.29 | 0 | 0% |
| Q2 2025 | 550,683 | $25.49B | $46290.00 | -46,745 | -8% |
| Q1 2025 | 597,428 | $36.44M | $60.99 | 0 | 0% |
| Q1 2025 | 597,428 | $36.44B | $60989.95 | -92,824 | -13% |
| Q4 2024 | 690,252 | $39.04M | $56.56 | 0 | 0% |
| Q4 2024 | 690,252 | $39.04B | $56559.86 | -135,856 | -16% |
| Q3 2024 | 826,108 | $42.74B | $51739.97 | -1,150 | 0% |
| Q2 2024 | 827,258 | $34.36B | $41529.41 | -4,733 | -1% |
| Q1 2024 | 831,991 | $45.12B | $54229.82 | -1,925 | 0% |
| Q4 2023 | 833,916 | $42.79B | $51310.10 | — | NEW |